DRL launches Cefixime for oral suspension
The drug is a generic version of Suprax, approved by the US FDA
Author
Vyome Biosciences appoints Angelo Secci as Chief Medical Officer
He will be responsible for leading Vyome’s clinical development, including the clinical programme of lead molecule, VB 1953, for…
Jubilant Life gets US FDA nod for anti-inflammatory drug
Indomethacin capsules are used in the treatment of moderate to severe inflammation and reduce pain
DRL announces the launch of Cefixime in the US
It is a therapeutic equivalent generic version of Suprax
Danone India launches Neocate in India
Neocate is a hypoallergenic, amino acid-based formula (AAF) intended for use in dietary management of cow’s milk allergy
Ministry of Law and Justice rejects pharma marketing rules
The rejection is a setback for public health groups that have been pushing for rules on marketing to curb bribery and corruption
Zydus Cadila to market anti-psychotic drug
The drug is used to treat schizophrenia and the manic symptoms of bipolar disorder, has received US FDA approval
Lupin launches generic Seroquel XR tabs in US
It is indicated for the treatment of schizophrenia; acute manic or mixed episodes in bipolar I disorder
Glenmark receives ANDA approval for Triamcinolone Acetonide Ointment
It is the generic version of Kenalog Ointment, 0.1 per cent, of Mylan Pharmaceuticals
DRL out-licenses DFD-06 to Encore Dermatology
The drug is intended to be used for treatment of moderate to severe plaque psoriasis.